Jacobsen, Daniel P. http://orcid.org/0000-0003-3229-6830
Røysland, Ragnhild
Strand, Heidi
Moe, Kjartan
Sugulle, Meryam
Omland, Torbjørn
Staff, Anne Cathrine
Funding for this research was provided by:
Helse Sør-Øst RHF (2019012)
University of Oslo
Article History
Received: 2 May 2022
Accepted: 1 June 2022
First Online: 7 July 2022
Declarations
:
: Roche Diagnostics donated biomarker reagents in-kind (cTnT, NT-proBNP and GDF-15). Anne Cathrine Staff has received recompensation from Roche Diagnostics for Advisory board service in 2018 regarding preeclampsia screening. Roche Diagnostics had no further involvement in study planning, collection or interpretation of data, writing of the manuscript, or the decision to submit the article for publication.
: The study was approved by the Regional committee for Medical and Health Research Ethics in South-Eastern Norway, and conducted in accordance with the principles of the Helsinki Declaration.
: All women included provided informed written consent.